Two enzyme structures vetted with Ramachandran plots before antidiabetic docking

Chemists used ProteinIQ's Ramachandran plot tool to vet two enzyme crystal structures before docking new metal complexes against diabetes targets.

2 min

Authors
Saira Nayab, Amjad Subhan, Haroon Ur Rashid, Sher Wali Khan, et al.
Published in
Bioorganic Chemistry · 2026-11 · Kyungpook National University
ProteinIQ in this study
Backbone dihedral angles of the α-glucosidase and α-amylase crystal structures were assessed with ProteinIQ's Ramachandran plot tool before docking.

A docking score is only as good as the receptor behind it. A crystal structure with a strained backbone can give a number that reflects the error and not the chemistry, so Saira Nayab, Amjad Subhan, Haroon Ur Rashid, Hyosun Lee and colleagues checked their enzymes before docking anything.

The team had built a Schiff base ligand from a methylfuran and a morpholine group and bound it to cobalt, copper, zinc and cadmium. Type 2 diabetes involves both blood sugar and oxidative stress, so a compound that tackles both is attractive. They solved X-ray structures for the complexes, then measured DPPH radical scavenging and inhibition of two carbohydrate-digesting enzymes, α-glucosidase and α-amylase.

Vetting the receptors

The docking targets came from the PDB: 3A4A for α-glucosidase and 1DHK for α-amylase. The ERRAT2 server checked non-bonded atom interactions for packing problems. The team then used the Ramachandran plot tool on ProteinIQ to count residues in the favored, allowed and outlier regions of the φ/ψ map. Their methods say:

In addition, the structures were also subjected to Ramachandran plot analysis using the web server ProteinIQ for assessing the stereochemical quality of the selected enzyme structures.

The reference list names the tool "Ramachandran Plot Generator Online" and gives an access date of 3 July 2026.

One outlier in 683 residues

Both structures passed. For α-glucosidase (3A4A), 572 of 584 residues (97.95%) were in favored regions and the other 12 (2.05%) in allowed regions, with no outliers. ERRAT2 gave the same structure an overall quality factor of 93.772%.

For α-amylase (1DHK), 663 of 683 residues across chains A and B (97.07%) were favored and 19 (2.78%) allowed. One residue, Ser8 of chain A, was an outlier (0.15%).

The complexes

The copper complex [Cu(MFM)Cl2] was the strongest antioxidant, with a DPPH IC50 of 3.01 μM, better than ascorbic acid. It also inhibited α-glucosidase with an IC50 of 5.22 μM, comparable to acarbose. The zinc complex [Zn(MFM)Cl2] was the best α-amylase inhibitor at 4.22 μM, which the authors report as clearly stronger than acarbose.

Docking scored -6.96 kcal/mol for copper with α-glucosidase and -7.24 kcal/mol for zinc with α-amylase. The authors call these preliminary and hypothesis-generating, because redocking confirmed the reference ligand poses but not the protocol for metal complexes. The assays carry the claim that zinc and copper furan-morpholine complexes are starting points for dual-action agents, and the structure checks show only that the enzyme models were sound to start from.

Focus on research, not infrastructure

Start free with 200 credits a month and no installs. Upgrade when your project needs more compute.